Brief: Taro Pharmaceutical Industries Terminates Agreement With Novabiotics
28/09/2018 22:16
Sept 28 (Reuters) - Taro Pharmaceutical Industries Ltd
TARO.N :
* TARO TERMINATES AGREEMENT WITH NOVABIOTICS
* TARO PHARMACEUTICAL INDUSTRIES LTD - HAS TERMINATED
LICENSE
AGREEMENT WITH NOVABIOTICS FOR ONYCHOMYCOSIS DRUG, NOVEXATIN
Source text for Eikon: ID:nBw8FBWyFa
Further company coverage: TARO.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Taro Pharmaceutical Industries
See all newsBrief: Taro Pharmaceutical Industries Says Taro Shareholders Approve Merger With Sun Pharma
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 31 cents a share - Earnings Preview
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
Brief: ISS, Glass Lewis Recommend Taro Shareholders Vote For Merger With Sun Pharma